DICE Therapeutics

📍 South San Francisco, United States🗓 Founded 2013👥 88 employees💰 Last funded 2021
Biotechnology Research🌐 dicetherapeutics.com
Website LinkedIn
At DICE, we are expecting more out of medicine. We design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. Through combining innovative chemistry with well-validated biology, our goal is to make medicines more accessible and unlock the potential of oral medicines. Our team is led by an exceptional group of scientists, R&D executives and company builders with demonstrated track records of progressing programs from discovery through regulatory approval and commercialization. Together, we’re building a team that has a passion for innovation and extensive experience in small molecule drug discovery and development.
4
Total investors
0
Early stage
2
Mid stage
2
Late stage
2013
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2018–2021 · investors recorded per year
201822019120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in DICE Therapeutics?
DICE Therapeutics has 4 investors on record on gritt.io, 2 mid-stage and 2 late-stage investors.
When did DICE Therapeutics last raise funding?
The most recent investment in DICE Therapeutics recorded on gritt.io was in 2021.
When was DICE Therapeutics founded?
DICE Therapeutics was founded in 2013.
What industry is DICE Therapeutics in?
DICE Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is DICE Therapeutics based?
DICE Therapeutics is headquartered in South San Francisco, United States.